Therapeutic application of Endoret® (PRGF®) in orthopaedic surgery and sports medicine has been revealed as one of the most effective treatments for arthrosis, tendon, ligament and muscular injuries, as well as in the recuperation of fractures or surgical interventions.
The fact that it's in liquid form facilitates skin infiltration
It's an activated liquid formulation that, following skin infiltration, polymerises in a Fibrin Matrix allowing the balanced and gradual release of a large number of molecules, including growth factors and other proteins.
This formulation is used in minimally invasive treatments such as:
It can also be used in combination with the other formulations in surgeries.
The plasma rich in growth factors clot is a Fibrin Matrix that polymerises after controlled activation with calcium.
In combination with the other formulations in the treatment of wounds and ulcers, it favours tissue regeneration and acts as an excellent system for the balanced and gradual release of a high number of molecules, including growth factors and other proteins.
It can be used in Orthopedic Surgery and Sports Medicine in the treatment of:
The combined graft, made from a plasma rich in growth factors clot and biomaterial, is used in surgical treatments where it is necessary to encourage osteosynthesis:
The autologous fibrin membrane has elastic and plastic properties. It is resistant, stichable, easy to handle and fully resorbable. It is used for surgical wound closure, to contain combined grafts and clots and to prevent adhesions.